Noah Medical Corporation, often referred to simply as Noah Medical, is a pioneering company headquartered in the United States, with significant operations across various regions. Founded in 2018, the company has quickly established itself within the medical technology industry, focusing on innovative solutions for minimally invasive procedures. Specialising in advanced robotic systems and AI-driven technologies, Noah Medical's flagship product, the AURORA system, stands out for its precision and efficiency in lung biopsies. This unique approach not only enhances patient outcomes but also streamlines the workflow for healthcare professionals. With a commitment to transforming the landscape of interventional medicine, Noah Medical has garnered recognition for its cutting-edge advancements, positioning itself as a leader in the field. The company continues to push the boundaries of medical innovation, striving to improve patient care and operational efficiency in healthcare settings.
How does Noah Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Noah Medical Corporation's score of 12 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Noah Medical Corporation, headquartered in the US, currently does not have any publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Noah Medical Corporation's climate commitments and initiatives remain unclear. Without emissions data or reduction strategies, it is challenging to assess their environmental impact or commitment to sustainability. The company may need to establish clear climate goals and reporting practices to align with industry standards and demonstrate accountability in addressing climate change.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Noah Medical Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
